Successful treatment of neuro-Behcet's disease with infliximab: four years follow-up

被引:1
作者
Kaur, Manjinder [1 ]
Nia, Emily S. [2 ]
Millius, Rebecca A. [3 ]
Sudano, Dominick G. [4 ]
Lisse, Jeffrey R. [4 ]
机构
[1] Univ Arizona, Coll Med, Dept Internal Med, 1501 N Campbell Ave,Room 8303, Tucson, AZ 85724 USA
[2] Univ Arizona, Coll Med, Dept Radiol, Tucson, AZ 85724 USA
[3] Univ Arizona, Coll Med, Dept Pathol, Tucson, AZ 85724 USA
[4] Univ Arizona, Coll Med, Dept Rheumatol, Tucson, AZ 85724 USA
关键词
Neuro-Behcet's disease; cerebral vasculitis; steroids; immunosuppressants; infliximab;
D O I
10.4081/rr.2015.6115
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuro-Behcet's disease (NBD) is a rare but severe manifestation of Behcet's disease. Patients with NBD tend to have high morbidity and mortality. Some patients do not respond adequately to conventional therapy (corticosteroids and immunosuppressants). This has led to treatment gaps in the therapy of NBD. There are reports in the literature of patients with Behcet's disease responding to anti-TNF therapy. We present a case of a male patient with biopsy proven cerebral vasculitis presenting as NBD who has been in remission with near resolution of cerebral magnetic resonance imaging lesions for 4 years following treatment with infliximab and azathioprine.
引用
收藏
页码:14 / 16
页数:3
相关论文
共 15 条
[1]   Anti-tumor necrotic factor antibody for treatment of neuro-Behcet's disease, a case report [J].
Borhani-Haghighi, A. ;
Safari, A. .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (03) :315-316
[2]   Infliximab monotherapy for neuro-Behcet's disease: A case report [J].
Di Filippo, Massimiliano ;
Di Gregorio, Maria ;
Nannini, Carlotta ;
Gaetani, Lorenzo ;
Gallina, Cristina ;
Floridi, Piero ;
Sarchielli, Paola ;
Calabresi, Paolo ;
Cantini, Fabrizio .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 347 (1-2) :389-390
[3]   Infliximab monotherapy in Neuro-Behcet's disease: Four year follow-up in a long-standing case resistant to conventional therapies [J].
Fasano, Alfonso ;
D'Agostino, Magda ;
Caldarola, Giacomo ;
Feliciani, Claudio ;
De Simone, Clara .
JOURNAL OF NEUROIMMUNOLOGY, 2011, 239 (1-2) :105-107
[4]   One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behcet's disease refractory to standard immunosuppressive drugs [J].
Giardina, AnnaRita ;
Ferrante, Angelo ;
Ciccia, Francesco ;
Vadala, Maria ;
Giardina, Ennio ;
Triolo, Giovanni .
RHEUMATOLOGY INTERNATIONAL, 2011, 31 (01) :33-37
[5]   Histopathology of central nervous system lesions in Behget's disease [J].
Hirohata, Shunsei .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 267 (1-2) :41-47
[6]   Manifestations of Neuro-Behcet's disease - Report of two cases and review of the literature [J].
Ho, CL ;
Deruytter, MJ .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2005, 107 (04) :310-314
[7]   Case of neuro-Behcet's disease successfully maintained a remission using infliximab for 2 years [J].
Kanemaru, Hisashi ;
Makino, Takamitsu ;
Jinnin, Masatoshi ;
Yonemitsu, Aya ;
Makino, Katsunari ;
Ihn, Hironobu .
JOURNAL OF DERMATOLOGY, 2013, 40 (08) :632-634
[8]   Effect of Infliximab on Gene Expression Profiling in Behcet's Disease [J].
Keino, Hiroshi ;
Watanabe, Takayo ;
Taki, Wakako ;
Okada, Annabelle A. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (10) :7681-7686
[9]   Effect of infliximab in progressive Neuro-Behcet's syndrome [J].
Kikuchi, Hirotoshi ;
Aramaki, Kaori ;
Hirohata, Shunsei .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 272 (1-2) :99-105
[10]  
Kose Osman, 2012, Patholog Res Int, V2012, P261989, DOI 10.1155/2012/261989